Skip to content
ELVElevance Health

ELV Earnings

Elevance Health next reports earnings on July 15, 2026. Track record: 4/4 beats.

Earnings Reported

July 15, 2026

Current Price

$390.33

EPS Estimate

Earnings Per Share

$4.72

-21.7% YoY

Trailing EPS

Last 12 months earnings

$21.59

Beat Rate

4/4

100%

Forward P/E

Price-to-Earnings ratio

13.1

Margin: 2.6%

Analyst Rating

Buy

21 analysts

Analyst Sentiment

Buy21 analysts
Target: $447.62+14.7%Full analysis →

Earnings History

4/4 Beats
QuarterEPS Est.EPS ActualSurpriseResult
2026-06-30$6.21$7.45+20.0%Beat
2026-03-31$10.81$12.58+16.4%Beat
2025-12-31$3.09$3.33+7.6%Beat
2025-09-30$4.94$6.03+22.0%Beat

Growth Estimates

PeriodEPS Est.Growth
Current Qtr(0q)$4.72-21.7%
Next Qtr(+1q)$2.63-20.9%
Current Year(0y)$27.07-10.6%
Next Year(+1y)$29.71+9.7%

Next Quarter Estimates

EPS Estimate

Earnings Per Share

$4.72

Revenue Estimate

$49.2B

Annual EPS Est.

$27.07

-10.6% YoY

ELV Earnings FAQ

When is ELV's next earnings date?

Elevance Health (ELV) is expected to report earnings on July 15, 2026. The consensus EPS estimate is $4.72.

Does ELV usually beat earnings estimates?

Elevance Health has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).

What is ELV's trailing EPS?

Elevance Health's trailing twelve-month EPS is $21.59. This is calculated from the last four quarters of reported earnings.

What do analysts think about ELV?

21 Wall Street analysts cover Elevance Health. The consensus rating is "Buy" with an average price target of $447.62, implying 14.7% upside from the current price.